Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol.
Saved in:
| Title: | Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocol. |
|---|---|
| Authors: | Hentzien M; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; University of Reims Champagne-Ardenne, Reims, France., Bonnet F; CHU de Bordeaux, Hôpital Saint-André, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France.; Université de Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, F-33000, France., Bernasconi E; Department of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland., Biver E; Division of Bone Diseases, Geneva University Hospitals, Geneva, Switzerland., Braun DL; Division Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Munting A; Service of Infectious Diseases, Centre Hospitalier Universitaire Vaudoise (CHUV), Lausanne, Switzerland., Leuzinger K; Clinical Virology, University Hospital Basel, Basel, Switzerland., Leleux O; Université de Bordeaux, INSERM, Institut Bergonié, BPH, U1219, CIC-EC 1401, Bordeaux, F-33000, France., Musardo S; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland., Prendki V; Division of Infectious Disease, Geneva University Hospital, Geneva, Switzerland., Schmid P; Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital, St Gallen, Switzerland., Staehelin C; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland., Stoeckle M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Walti CS; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Wittkop L; CHU de Bordeaux, Hôpital Saint-André, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, France.; CHU de Bordeaux, Service d'information médicale, INSERM, Institut Bergonié, CIC-EC 1401, Bordeaux, F-33000, France.; Inria équipe SISTM team, Talence, France., Appay V; Université de Bordeaux, CNRS UMR 5164, INSERM ERL 1303, ImmunoConcEpT, Bordeaux, 33000, France., Didierlaurent AM; Department of Pathology and Immunology, Center of Vaccinology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. arnaud.didierlaurent@unige.ch., Calmy A; HIV/AIDS Unit, Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. Alexandra.Calmy@hug.ch. |
| Source: | BMC infectious diseases [BMC Infect Dis] 2024 Mar 19; Vol. 24 (1), pp. 329. Date of Electronic Publication: 2024 Mar 19. |
| Publication Type: | Clinical Trial Protocol; Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1471-2334 |
|---|---|
| DOI: | 10.1186/s12879-024-09192-5 |
